Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

UPDATE 2-Tropical Malaysia works to boost cold-storage, get more COVID-19 shots

Wed, 23rd Dec 2020 07:47

* Delivery map for vaccines needing ultra-cold storage

* Final talks with Russian and Chinese vaccine makers

* Aims to double AstraZeneca vaccines, buy more from Pfizer

* In talks with Moderna Inc, Johnson & Johnson
(Recasts, adds details on vaccine logistics)

By Liz Lee

KUALA LUMPUR, Dec 23 (Reuters) - Malaysia said on Wednesday
it was talking with Pfizer and other companies to secure
more COVID-19 vaccine doses to cover 83% of its population, and
is drawing up plans to arrange ultra-cold storage in its
tropical heat.

The Southeast Asian nation says it has so far got enough
doses to inoculate 40% of its 32 million people, and has
promised to spend $500 million to buy enough vaccines.

The government, which has struck a deal to buy 12.8 million
doses of U.S. drugmaker Pfizer-BioNTech's shot, said it was in
talks for an option to buy more doses to cover another fifth of
the population.

It is also in final talks to secure a total of 23.9 million
doses from Chinese manufacturers Sinovac Biotech Ltd and
CanSino Biologics, and from Russia's Gamaleya Institute, the
maker of the Sputnik V vaccine, Science Minister Khairy
Jamaluddin said.

It will secure additional AstraZeneca vaccines under
the global COVAX facility, and has begun talks with Moderna
and Johnson & Johnson as a buffer, the minister
added.

Malaysia, where temperatures average 30 degrees Celsius
year-round, wants to ensure a distribution network that does not
need to store vaccines for long, Khairy said.

"Once the Pfizer vaccines come in, we are hoping that it
will be a just-in-time roll out of vaccination," he said.

Pfizer's vaccines need to be stored and transported at minus
70 degrees Celsius (-94F), although they can be kept in a fridge
for up to five days, or up to 15 days in a thermal shipping box.

Some Asian countries have expressed reservations about the
Pfizer vaccine due to tropical heat, remote island communities
and a lack of ultra-cold freezers.

Malaysian's vaccine supply committee will identify
ultra-cold storage facilities and aims to stagger distribution
to ensure coverage in remote regions, ahead of the arrival of
Pfizer's first shipment in February, Khairy said.

Neighbouring Singapore was the first Asian nation to take
delivery of a batch of the Pfizer vaccine on Monday from
Belgium.

(Writing by Rozanna Latiff; Editing by Himani Sarkar, Michael
Perry abd Andrew Heavens)

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.